The Wikileaks lessons for business in emerging markets
This article was originally published in SRA
Executive Summary
OK, now that we're past the easy Big Bad Pharma headlines with Pfizer making an unwanted appearance in the leaked mountain of US confidential diplomatic cables on Wikileaks – what else can be learned about the business from this embassy dispatch from Nigeria?